Keystone Research

Austin, Texas 78751

1 studies enrolling now · 13 studies all time

What they study most

Aphakia, Astigmatism, Corneal Edema After Cataract Surgery, Dry Eye Disease, Glaucoma, Glaucoma, Open-Angle, Inflammation, Mydriasis, Neovascular Age-Related Macular Degeneration, Ocular Hypertension, Presbyopia, Pterygium

Studies at this site

• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. — Recruiting now
• A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery — Completed
• RMP-A03 Ocular Suspension in Patients With Pterygium — Completed
• Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension — Completed
• Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3) — Completed
• Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery — Completed
• Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration — Running, not enrolling
• A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease — Completed
• Rocklatan® Evaluation — Completed
• Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs — Completed
• Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation — Completed
• iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study — Status unconfirmed
• Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting — Completed